Cannabis Business Insights Magazine
#
  • Home
  • Topics
    Cannabis Consulting
    Cannabis Distributor
    Cannabis Extraction
    Cannabis Insurance Brokerage
    Cannabis Logistics
    Cannabis Marketing
    Cannabis Packaging
    Cannabis Testing
    Medical Cannabis
    Cannabis Consulting
    Cannabis Distributor
    Cannabis Extraction
    Cannabis Insurance Brokerage
    Cannabis Logistics
    Cannabis Marketing
    Cannabis Packaging
    Cannabis Testing
    Medical Cannabis
  • Leadership Perspectives
  • Industry Intelligence
  • News
  • Magazine
  • Conferences
  • CXO Awards
  • About Us
  • APAC
    • US
    • EUROPE
    • APAC
    • CANADA
  • Home
    • Cannabis Consulting
    • Cannabis Distributor
    • Cannabis Extraction
    • Cannabis Insurance Brokerage
    • Cannabis Logistics
    • Cannabis Marketing
  • Topics
    • Cannabis Consulting
      Cannabis Distributor
      Cannabis Extraction
      Cannabis Insurance Brokerage
      Cannabis Logistics
      Cannabis Marketing
      Cannabis Packaging
      Cannabis Testing
      Medical Cannabis
      Cannabis Consulting
      Cannabis Distributor
      Cannabis Extraction
      Cannabis Insurance Brokerage
      Cannabis Logistics
      Cannabis Marketing
      Cannabis Packaging
      Cannabis Testing
      Medical Cannabis
  • Leadership Perspectives
  • Industry Intelligence
  • News
  • Magazine
  • Conferences
  • CXO Awards
  • About Us
    • APAC
      • US
      • EUROPE
      • APAC
      • CANADA

CannaSense has been recognized by Cannabis Business Insights as "Top Medical Cannabis Products 2025" based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Cannabis Business Insights research and editorial team based on insights from an interview with Neil Schloss, Founder and CEO.

CannaSense

Medical Cannabis made Accessible
CannaSense
Neil Schloss, CannaSense | Cannabis Business Insights | Top Medical Cannabis ProductsNeil Schloss, Founder and CEO
Medical cannabis has gained recognition as a clinically proven form of medicine, offering relief to patients managing chronic and neurological illnesses. Despite its promise, access remains limited by restrictive laws in many regions.

CannaSense was founded to address this disparity.

“Patients once had to travel across the country to have access to medical cannabis,” says Neil Schloss, founder and CEO. “With CannaSense, they can now complete the entire process from home, safely and legally.”

For Schloss, the lack of access to medical cannabis had a profound impact when his mother passed away after battling breast cancer. Soon after the personal loss, he learned about medical cannabis and discovered Rick Simpson Oil (RSO), which was gaining attention for its medical benefits. Access to such products on the East Coast was nonexistent, prompting him to find compliant, patient-safe alternatives. He founded CannaSense with a vision to create a system that combines technology with compliance to ensure safe and reliable care.

CannaSense unites healthcare professionals, caregivers and patients within a protected, web-based system. This enables consultations, verification and product fulfillment, all in adherence with the Compassionate Use Act of 1996, the first U.S. law to establish medical cannabis standards and patient protection.

Today, it operates as a total wellness provider that integrates education, medical evaluation and safe product distribution into one seamless process. Through its secure online system, patients can consult licensed physicians, an option later reinforced by the Affordable Healthcare Act, and receive valid recommendations for treatment.
  • Patients once had to travel across the country to have access to medical cannabis. With CannaSense, they can now complete the entire process from home, safely and legally.


Following physician approval, patients are given access to a secure portal where they can select the finest medicinal cannabis products in various forms, including vape, tincture, topical and edibles. All orders are provided through reputable carriers, with comprehensive tracking provided for transparency and assurance.

These products are effective for a range of conditions, including cancer, PTSD, Parkinson’s disease and chronic pain. Patients often report relief, improved sleep and better quality of life.

CannaSense rigorously tests and verifies every product in its inventory to ensure it meets the highest standards of purity and potency. Behind every package is a chain of accountability built to protect patient and provider, ensuring that wellness never comes at the cost of safety.

Education remains central to that belief. Many patients do not fully understand the legal or scientific frameworks surrounding medical cannabis, and part of the collective’s mission is to make those systems understandable. Each member gains access to resources on responsible usage, dosage and product selection, guided by licensed medical professionals. It helps patients become informed participants in their own care rather than passive recipients.

The platform’s credibility has earned the trust of thousands who value discretion, legality and compassion in one accessible framework.

Among the many patients it has served, one stands out as a reminder of why the effort matters. A woman diagnosed with two cancerous tumors underwent surgery and, instead of pursuing chemotherapy or radiation, began a treatment plan that included RSO through the collective. Within months, her bloodwork showed no remaining cancer, and she has been in remission for nine years while maintaining a small nightly dose. Her sisters, who faced the same illness but followed conventional treatment, were not as fortunate. Her message captures the purpose behind the entire initiative, where access can change outcomes and compassion can save lives.

Each step, from doctor consultation to delivery, is protected by HIPAA-compliant systems that uphold patient privacy while maintaining full transparency for regulatory authorities. With the emergence of new compounds like CBD, CBG and CBN, CannaSense continues to refine its product formulations to better align with individual patient needs.

CannaSense stands as a testament to how innovation, empathy and compliance can work together for the greater good. By combining modern telemedicine with scientific integrity, the company has redefined what access to medical cannabis can mean, turning an act of care into a movement of empowerment and healing.
Top Medical Cannabis Products 2025

Company : CannaSense

Headquarters :

.
Management
Neil Schloss, Founder and CEO
Medical Cannabis | Cannabis Business Insights

Thank you for Subscribing to Cannabis Business Insights Weekly Brief

Linked
  • Sitemap
  • About Us
  • Advertise

    with us

  • Home
  • News
  • Leadership Perspectives
  • Magazine
  • Conferences
  • Newsletter
  • Subscribe
  • Editorial Policy
  • Feedback Policy
  • Advertise

    with us

Copyright © 2026 Cannabis Business Insights. All rights reserved.

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.cannabisbusinessinsightsapac.com/cannasense